Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opioid-sparing anesthesia for bariatric surgery
PACTR201911712319290Phase 3Recruiting
- Sponsor
- Mona Raafat Elghamry
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of dexmedetomidine in obesity (2 arms), sponsored by Mona Raafat Elghamry. Primary endpoint: Postoperative opioid requirements. Started Nov 2019; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
obesity
Beyond the preview
Go deeper on PACTR201911712319290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201911712319290.